Lung-Resident Mesenchymal Stem Cells Promote Repair of LPS-Induced Acute Lung Injury via Regulating the Balance of Regulatory T cells and Th17 cells

Inflammation

Volumn 42, Issue 1, 2019, Pages 199-210

  Wang, Linlin ^a   Shi, Meng ^b   Tong, Lin ^a   Wang, Jian ^a   Ji, Shimeng ^a   Bi, Jing ^a   Chen, Cuicui ^a   Jiang, Jinjun ^a   Bai, Chunxue ^a   Zhou, Jian ^a   Song, Yuanlin ^a,c  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c SHANGHAI PUBLIC HEALTH CLINICAL CENTER   (China)

Author keywords

Acute lung injury; Lung resident mesenchymal stem cells; Th17 cells; Tregs

Indexed keywords

COLLAGEN; CYTOKINE; SURFACTANT PROTEIN C; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; CONTROLLED STUDY; DOWN REGULATION; DRY WEIGHT; FLOW CYTOMETRY; HISTOPATHOLOGY; INFLAMMATORY CELL; LIPOPOLYSACCHARIDE-INDUCED ACUTE LUNG INJURY; LUNG INJURY; MALE; MESENCHYMAL STEM CELL; NONHUMAN; PLASMA; RAT; REGULATORY T LYMPHOCYTE; SPLEEN; TH17 CELL; UPREGULATION; ACUTE LUNG INJURY; ANIMAL; CELL MOTION; CHEMICALLY INDUCED; CYTOLOGY; LUNG; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; PATHOLOGY; PHYSIOLOGY; PROCEDURES;

ACUTE LUNG INJURY; ANIMALS; CELL COUNT; CELL MOVEMENT; LIPOPOLYSACCHARIDES; LUNG; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 85052921808     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-018-0884-6     Document Type: Article

References (29)

1. Ware, L.B., and M.A. Matthay. 2000. The acute respiratory distress syndrome. The New England Journal of Medicine 342: 1334–1349.
2. Rubenfeld, G.D., E. Caldwell, E. Peabody, J. Weaver, D.P. Martin, M. Neff, E.J. Stern, and L.D. Hudson. 2005. Incidence and outcomes of acute lung injury. The New England Journal of Medicine 353: 1685–1693.
3. Matthay, M.A., L.B. Ware, and G.A. Zimmerman. 2012. The acute respiratory distress syndrome. The Journal of Clinical Investigation 122 (8): 2731–2740.
4. Calfee, C.S., and M.A. Matthay. 2007. Nonventilatory treatments for acute lung injury and ARDS. Chest 131 (3): 913–920.
5. Lee, J.W., X. Fang, N. Gupta, V. Serikov, and M.A. Matthay. 2009. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proceedings of the National Academy of Sciences of the United States of America 106 (38): 16357–16362.
6. Sakaguchi, S. 2004. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annual Review of Immunology 22: 531–562.
7. D'Alessio, F.R., K. Tsushima, N.R. Aggarwal, E.E. West, M.H. Willett, M.F. Britos, M.R. Pipeling, R.G. Brower, R.M. Tuder, J.F. McDyer, and L.S. King. 2009. CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. The Journal of Clinical Investigation 119: 2898–2913.
8. Garibaldi, B.T., F.R. D'Alessio, J.R. Mock, D.C. Files, E. Chau, Y. Eto, M.B. Drummond, N.R. Aggarwal, V. Sidhaye, and L.S. King. 2013. Regulatory T cells reduce acute lung injury fibroproliferation by decreasing fibrocyte recruitment. American Journal of Respiratory Cell and Molecular Biology 48: 35–43.
9. Ji, Y.Q., and W.G. Zhang. 2010. Th17 cells: positive or negative role in tumor? Cancer Immunol Immun 59 (7): 979–987.
10. Yu, Z.X., M.S. Ji, J. Yan, Y. Cai, J. Liu, H.F. Yang, Y. Li, Z.C. Jin, and J.X. Zheng. 2015. The ratio of Th17/Treg cells as a risk indicator in early acute respiratory distress syndrome. Critical Care 19: 82.
11. Mei, S.H., S.D. McCarter, Y. Deng, C.H. Parker, W.C. Liles, and D.J. Stewart. 2007. Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Medicine 4: e269.
12. Ortiz, L.A., M. Dutreil, C. Fattman, A.C. Pandey, G. Torres, K. Go, and D.G. Phinney. 2007. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proceedings of the National Academy of Sciences of the United States of America 104: 11002–11007.
13. Mei, S.H., J.J. Haitsma, C.C. Dos Santos, Y. Deng, P.F.H. Lai, A.S. Slutsky, W.C. Liles, and D.J. Stewart. 2010. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. American Journal of Respiratory and Critical Care Medicine 182: 1047–1057.
14. Ghannam, S., J. Pène, G. Moquet-Torcy, C. Jorgensen, and H. Yssel. 2010. Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype. Journal of Immunology 185 (1): 302–312.
15. Luz-Crawford, P., M. Kurte, J. Bravo-Alegría, R. Contreras, E. Nova-Lamperti, G. Tejedor, D. Noël, C. Jorgensen, F. Figueroa, F. Djouad, and F. Carrión. 2013. Mesenchymal stem cells generate a CD4+CD25+Foxp3+regulatory T cell population during the differentiation process of Th1 and Th17 cells. Stem Cell Research & Therapy 4 (3): 65.
16. Tong, L., J. Zhou, L. Rong, E.J. Seeley, J. Pan, X. Zhu, J. Liu, Q. Wang, X. Tang, J. Qu, C. Bai, and Y. Song. 2016. Fibroblast growth factor-10 (FGF-10) mobilizes lung-resident mesenchymal stem cells and protects against acute lung injury. Scientific Reports 6: 21642.
17. Gupta, N., X. Su, B. Popov, J.W. Lee, V. Serikov, and M.A. Matthay. 2007. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. Journal of Immunology 179 (3): 1855–1863.
18. Xu, J., C.R. Woods, A.L. Mora, R. Joodi, K.L. Brigham, S. Iyer, and M. Rojas. 2007. Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice. American Journal of Physiology. Lung Cellular and Molecular Physiology 293 (1): L131–L141.
19. Hao, Q., Y.G. Zhu, A. Monsel, S. Gennai, T. Lee, F. Xu, and J.W. Lee. 2015. Study of bone marrow and embryonic stem cell-derived human mesenchymal stem cells for treatment of Escherichia coli endotoxin-induced acute lung injury in mice. Stem Cells Translational Medicine 4 (7): 832–840.
20. Kim, E.S., Y.S. Chang, S.J. Choi, J.K. Kim, H.S. Yoo, S.Y. Ahn, D.K. Sung, S.Y. Kim, Y.R. Park, and W.S. Park. 2011. Intratracheal transplantation of human umbilical cord blood-derived mesenchymal stem cells attenuate Escherichia coli-induced acute lung injury in mice. Respiratory Research 12: 108.
21. Xiang B, Chen L, Wang X, Zhao Y, Wang Y, Xiang C. 2017. Transplantation of menstrual blood-derived mesenchymal stem cells promotes the repair of LPS-induced acute lung injury. International Journal of Molecular Sciences 18(4).
22. Ortiz, L.A., F. Gambelli, C. McBride, D. Gaupp, M. Baddoo, N. Kaminski, and D.G. Phinney. 2003. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proceedings of the National Academy of Sciences of the United States of America 100 (14): 8407–84011.
23. Xu, J., J. Qu, L. Cao, Y. Sai, C. Chen, L. He, and L. Yu. 2008. Mesenchymal stem cell-based angiopoietin-1 gene therapy for acute lung injury induced by lipopolysaccharide in mice. The Journal of Pathology 214 (4): 472–481.
24. Psaltis, P.J., A.C. Zannettino, S.G. Worthley, and S. Gronthos. 2008. Mesenchymal stromal cells: potential for cardiovascular repair. Stem Cells 26 (9): 2201–2210.
25. Hocking, A.M., and N.S. Gibran. 2010. Mesenchymal stem cells: paracrine signaling and differentiation during cutaneous wound repair. Experimental Cell Research 316 (14): 2213–2219.
26. Baba, Y., T. Yazawa, Y. Kanegae, S. Sakamoto, I. Saito, N. Morimura, T. Goto, Y. Yamada, and K. Kurahashi. 2007. Keratinocyte growth factor gene transduction ameliorates acute lung injury and mortality in mice. Human Gene Therapy 18 (2): 130–141.
27. Bao, S., Y. Wang, P. Sweeney, A. Chaudhuri, A.I. Doseff, C.B. Marsh, and D.L. Knoell. 2005. Keratinocyte growth factor induces Akt kinase activity and inhibits Fas-mediated apoptosis in A549 lung epithelial cells. American Journal of Physiology. Lung Cellular and Molecular Physiology 288 (1): L36–L42.
28. Augello, A., R. Tasso, S.M. Negrini, A. Amateis, F. Indiveri, R. Cancedda, and G. Pennesi. 2005. Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. European Journal of Immunology 35 (5): 1482–1490.
29. Luz-Crawford, P., D. Noël, X. Fernandez, M. Khoury, F. Figueroa, F. Carrión, C. Jorgensen, and F. Djouad. 2012. Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway. PLoS One 7 (9): e45272.